Results 181 to 190 of about 160,099 (251)

Interleukin‐5, Eosinophils, and Interleukin‐5 Pathway Inhibitors in Eosinophilic Granulomatosis With Polyangiitis

Arthritis &Rheumatology, EarlyView.
Interlukin‐5 (IL‐5) plays a crucial role in the pathogenesis of eosinophilic granulomatosis with polyangiitis (EGPA) by promoting eosinophil differentiation, activation, and survival. We present here a typical case of EGPA in which treatment with IL‐5 pathway inhibitors is prescribed, showing to be beneficial for the patient.
Alvise Berti, Christian Pagnoux
wiley   +1 more source

Biomechanical and physiological effects of a passive upper-body exoskeleton during stair ascent and descent. [PDF]

PLoS One
Garcia G, Espoz M, Albuja C, Yañez R, Arauz PG, Martin BJ.   +5 more
europepmc   +1 more source

Wing hinge dynamics influence stroke amplitudes in flapping wing insects: a frequency response approach. [PDF]

J R Soc Interface
Casey CB, Cote B, Heveran C, Jankauski M.   +3 more
europepmc   +1 more source

Exposure to Occupational Inhalants and the Risk of Developing Rheumatoid Arthritis: A Systematic Review and Meta‐Analysis

Arthritis &Rheumatology, EarlyView.
Objective Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by joint pain, swelling, and stiffness. Although smoking is a well‐established risk factor for RA, the role of occupational inhalants in RA development is less well recognized.
Qianwen Liu, Xin Song, Emily Mauro, Yuan Jiang, Klementy Shchetynsky, Lars Klareskog, Lars Alfredsson, Xia Jiang   +7 more
wiley   +1 more source

Changes in diagnostic evaluation of patients with lung cancer symptoms. [PDF]

NPJ Prim Care Respir Med
Sætre LMS, Balasubramaniam K, Wehberg S, Laursen CB, Søndergaard J, Jarbøl DE.   +5 more
europepmc   +1 more source

Impact of evolving treatment patterns on interstitial lung disease progression in systemic sclerosis using the EUSTAR database

Arthritis &Rheumatology, Accepted Article.
Background The treatment landscape for systemic sclerosis‐associated interstitial lung disease (SSc‐ILD) has evolved with increasing immunosuppressive (IST) and anti‐fibrotic therapies available. However, their real‐world use remains unclear. Objectives To analyze treatment trends and the effect of IST and anti‐fibrotic therapies on ILD progression ...
Corrado Campochiaro, Marie‐Elise Truchetet, Madelon Vonk, Giacomo De Luca, Giovanna Cuomo, Lidia P. Ananieva, Eric Hachulla, Vanessa Smith, Ana Maria Gheorghiu, Radim Becvar, Patricia Carreira, Nicolas Hunzelmann, Daniel E. Furst, Vera Ortiz‐Santamaria, Francesco Del Galdo, Marco Matucci‐Cerinic, Anna‐Maria Hoffmann‐Vold, EUSTAR collaborators   +17 more
wiley   +1 more source

Cytisinicline for smoking cessation in individuals with self-reported COPD: a post hoc analysis of the ORCA-2 and ORCA-3 trials. [PDF]

Thorax
Prochaska J, Rubinstein M, Perdok R, Blumenstein B, Jacobs C.   +4 more
europepmc   +1 more source

Cough-Predominant Laryngeal Hypersensitivity Syndrome in a Middle-Aged Woman: A Case Report. [PDF]

Cureus
Iqbal MA, Mahmood R, Khalid MA, Mahmood MS, Khan MSA, Khan U.   +5 more
europepmc   +1 more source

Surgical treatment of traumatic manubrio-sternal dislocation type I associated with chondrosternal joint rupture. [PDF]

J Surg Case Rep
De Pauw V, Van Asbroeck E, Verfaillie G, Smets D.   +3 more
europepmc   +1 more source